STOCK BROKER REVIEW | INVESTING | UPCOMING IPO | ALGO TRADING | TECHNICAL ANALYSIS

Accretion Pharmaceuticals Limited IPO Review & Recommendations

 

Get Real-Time Updates on stock market trends and news

Get updates on stock market, Stock related news, Algo Trading, learn profitable strategies.

Join WhatsApp Channel

Accretion Pharmaceuticals Limited IPO

May 14, 2025 - May 16, 2025 Closed

Accretion Pharmaceuticals Limited IPO Review

Accretion Pharma company operates in the construction and marketing of tablets, capsules, oral liquid, external preparations (ointment, cream, gel, lotion, medicated shampoo, mouthwash, dust powder), and oral powder (bag, dry syrup), etc. In addition to producing direct sales products, Accrete Pharmaceutical Private Limited Company produces various drug products for different sectors based on a license or contract production. Their business is mainly carried out on a principal-to-principal basis with different elimination. As a date for this red acidic opportunity, they complete many corporate customers based on the loan license and/or contract production.

Accretion Pharmaceuticals Limited Products and Services

Accrete Pharmaceuticals Private Limited is engaged in different doses, oral fluid, external cooking (ointment, cream, gel, lotion, medicated shampoo, mouthwash, dust powder), and is engaged in business with production and marketing of tablets in capsules and oral powder (pos, dry syrup), etc. They are a medical contract development and production organization ("CDMO") that offers a comprehensive range of drug products and services. They run a production unit for their CDMO business.

Accretion Pharmaceuticals Ipo business process begins with order generation, followed by the purchase and receipt of raw materials. Once the materials are received, they undergo a quality assurance check to ensure compliance with industry standards. The approved materials then move into the manufacturing stage, where drugs are produced under strict guidelines. After manufacturing, a final quality check is conducted to maintain product integrity. The drugs are then packed and labeled appropriately before being supplied to marketers for distribution.

Financial Overview

APL deals with marketing and production of pharmaceutical products. A B2B model is largely working. The faster in the lower lines from FY24 increases the anxiety of the eyebrows and its stability. This contract production business containing large quantities, but a low margin. Depending on financial data, the problem seems aggressively priced. Well -informed investors can park funds for long periods.

Frequently Asked Question

Post-issue shareholding of the Accretion Pharmaceuticals Limited IPO promoter is 73.48%.
Opening date of Accretion Pharmaceuticals Limited IPO is May 14, 2025.
Accretion Pharmaceuticals Limited IPO Share price Shares will be listed at NSE SME.
You will receive on Accretion Pharmaceuticals Limited IPO shares in your Demat account on May 19, 2025, if allotted.
Pre-issue shareholding of the accrete pharmaceuticals private limited promoter is 100.00%.
IPO application is an online process by using UPI or ASBA as a payment method. ASBA IPO application is already available in the net banking of your respective bank account and the UPI application is offered by your Stockbroker, you can invest in Kenrik Industries Limited using any neatest method at your convenience.
An IPO “Initial Public Offering” is the process by which a private company offers that’s shares to the public for the first time to raise capital.
The meaning of "Accretion Pharmaceuticals Limited IPO" is the Grey Market Premium (GMP) for the initial public offering (IPO) of Accretion Pharmaceuticals Limited IPO on the current day.
Investors can check the status of their IPO application on the registrar's website by entering their application details or through their respective brokers.
Accretion Pharmaceuticals Limited IPO shares will get listed on May 21 2025.
The face value of Accretion Pharmaceuticals Limited IPO is ₹10 per share.
Key financial metrics, including revenue, profit margins, and other financial data, will be available in the company's prospectus and financial statements.
Lot size of the Accretion Pharmaceuticals Limited IPO is 1200 shares.
If you do not get the allotment of on Accretion Pharmaceuticals Limited IPO, your IPO application amount will be released or credited back to your bank account via which you applied for this IPO.
The price band for the Accretion Pharmaceuticals Limited IPO will be specified in the company's official prospectus.
Accretion Pharmaceuticals Limited IPO Products share price ₹96 to ₹101 per share.
Comments for Accretion Pharmaceuticals Limited IPO Review & Recommendations

0 comments